Brief: Matinas Biopharma Says MAT9001 Contract Manufacturer Suffered Explosion At Asia Manufacturing Facilities
Dec 28 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA - BECAME AWARE THAT A CONTRACT
MANUFACTURER OF
MAT9001 SUFFERED EXPLOSION AT ITS MANUFACTURING FACILITIES IN
ASIA
* MATINAS BIOPHARMA HOLDINGS INC - NONE OF COMPANY'S KEY
OMEGA-3
INTERMEDIATES STORED AT FACILITY WERE DAMAGED OR DESTROYED
Source text: [ID: https://bit.ly/2L1gYiy]
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing
Brief: Matinas Biopharma Holdings Inc Keith Kucinski Resigns As CFO Effective January 17, 2026
Brief: Matinas Biopharma Holdings Inc - CFO Keith Kucinski Resigns Effective January 17, 2026 - SEC Filing
Brief: Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma
Brief: Matinas BioPharma Appoints Seasoned Biotech Leaders To Board Of Directors